Human granulocytic ehrlichiosis (HGE), now known as anaplasmosis, is an intracellular gram-negative coccobacillus transmitted by the Ixodes tick. 1 The organism, Anaplasma phagocytophilum, is an obligate intracellular Rickettsia-like coccobacillus that replicates in the cytoplasmic vacuoles of granulocytes to form microcolonies called morulae. [2] [3] [4] The infection is most commonly found in the Midwestern and Northeastern parts of the United States, where prevalence rates have increased significantly. In New York state, tick-borne infections are endemic throughout the Hudson River Valley, and rates at Albany Medical Center have steadily increased since 2008. Most patients with anaplasmosis experience nonspecific flu-like symptoms, including fever, headache, myalgias, sweats, and malaise. Less common findings include nausea, vomiting, anorexia, Upon completion of this activity you will be able to:
• list the most common clinical features of anaplasmosis.
• outline criteria for diagnosis of anaplasmosis by examination of the peripheral blood smear.
• discuss the implications of an early diagnosis of anaplasmosis and list potential outcomes of delayed or missed diagnosis.
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and confusion. 5 Laboratory findings are also nonspecific and include leukopenia, atypical lymphocytes, thrombocytopenia, and elevated liver enzymes. While self-limiting in most patients, infections in humans have led to severe illness and even death. 5 Diagnosis is often made clinically and treated empirically before laboratory confirmation is available. This is in large part due to the reliance on polymerase chain reaction (PCR) and serologic tests, neither of which are readily available and require prolonged turnaround times. Anaplasma does not grow well in standard blood culture medium. 5 PCR is the gold standard of early diagnosis but can be timeconsuming and is not routinely available outside of specialty laboratories. Serologic tests are frequently negative during the first week of illness onset and often require both acute and convalescent titers to confirm a diagnosis. The peripheral smear, however, is a testing method that can be prepared and examined quickly. Organisms can be identified visually as punctate deep-blue to gray-blue coccobacilli arranged in spherical groups within the cytoplasm of granulocytes (morulae), providing prompt diagnosis so that appropriate therapy can be administered in a timely manner ❚Image 1❚. 5 However, the percentage of granulocytes that contain morulae is reportedly low, and there are no recommendations to help guide a strategy of examining peripheral smears in an effort to maximize the sensitivity of this simple and commonly available test. Criteria regarding the concentration and quantity of morulae have not yet been established. The objective of this study is to characterize the number of granulocytes needed to count on peripheral smear to identify morulae and develop criteria for the diagnosis of anaplasmosis via peripheral smears. In this retrospective case study, 14 cases of anaplasmosis were confirmed with PCR, serology, or examination of the peripheral smear with treatment response.
Materials and Methods
For the purposes of this study, peripheral smears were examined retrospectively in 14 hospitalized patients confirmed to have anaplasmosis. The mean age was 71.4 years (range, 57-95 years). There were three women and 11 men. Most patients were admitted to hospital in June followed by May and July 2011. The duration of hospital stay ranged from two to 27 days. All 14 patients had relatively severe symptoms requiring hospitalization. Patients exhibited symptoms before presentation between one and 28 days with a mean of 10.1 days. The most commonly reported symptoms were fever, myalgias, fatigue, chills, and headache. The most common signs were pancytopenia and atypical lymphocytes. A total of eight (57.1%) patients could recall a tick bite in the past 30 days. The cases were confirmed by various methods, including seven (50.0%) cases confirmed by PCR, five (35.7%) confirmed by serology, and two (14.3%) confirmed by examination of peripheral smear concurrent with hospitalization ❚Table 1❚.
All peripheral smears were prepared as part of routine complete blood counts at initial hospital presentation. The peripheral smears were prepared with Wright-Giemsa using Sysmex (Lincolnshire, IL) hematology automatic stainers. A retrospective analysis was performed on confirmed positive cases of anaplasmosis. The granulocytes of each smear were counted until a morula was identified. The total number of granulocytes containing morulae per 100 granulocytes was also recorded. If a morula was not identified before a count of 100 granulocytes, a count of 200 was performed and the number of morulae identified per 200 granulocytes was recorded. A separate category was created for cases that needed more than 100 granulocyte counts until morulae were identified. The mean counts of three pathologists (J.V.R., A.J.T., and S.M.H.) were calculated to determine the number of granulocytes needed to count to confidently identify a positive result or rule in a negative result.
Results and Discussion
In the 14 patients, morulae were identified before a count of 100 granulocytes in 11 (78.6%) cases and between 100 and 200 granulocytes in 3 (21.4%) cases. All 14 (100%) cases had morulae identified before counting 200 granulocytes. The ❚Image 1❚ Morulae can be identified within the cytoplasm of granulocytes as punctate deep blue coccobacilli arranged in spherical groups (Wright-Giemsa, ×100). mean number of granulocytes containing morulae found in cases with morulae identified before a count of 100 was 3.3, and the median number of granulocytes containing morulae in cases identified between 100 and 200 was 1.0.
This study suggests that to confirm that a case is positive, a minimum of 200 granulocytes should be evaluated for diagnostic morulae. Those cases in which morulae were identified in the first 100 granulocytes counted had the heaviest burden of disease (3.3 granulocytes with morulae). However, the results of this study show that 100 granulocytes may not be enough to confirm a positive test, as 21.4% of the cases needed an additional 100 granulocytes counted to identify a positive result. It was also observed that if a morula was not identified in the first 100 granulocytes counted, the average disease load in the peripheral smear decreased dramatically (by 87%) compared with the population at which morulae were identified before 100. This shows that while counting 100 granulocytes is a relatively reliable number needed to identify a positive result, the disease cannot always be confirmed until a count of 200 has been performed.
Conclusions
Peripheral smears are a useful, cost-effective, and timeeffective tool for diagnosing anaplasmosis. While PCR and serology are reliable diagnostic tools, rapid performance, cost, and accessibility are frequently lacking. The peripheral smear is both cost-and time-effective, but no clear guidelines regarding its role in the diagnosis of anaplasmosis have been established. This study demonstrates that in most patients requiring hospitalization due to anaplasmosis, morulae will be identified in a count of 100 granulocytes. Furthermore, a count of 200 granulocytes will further increase sensitivity in approximately 20% of patients with a relatively low burden of organisms. To our knowledge, this is the first study to provide a quantitative analysis for a recommendation to perform peripheral smear testing in an effort to rapidly and routinely confirm a diagnosis of anaplasmosis.
Several issues are raised by this study. Since all the patients were hospitalized, it is unclear how applicable our findings are to those infected individuals who do not require hospitalization. The sensitivity of peripheral smear analysis relative to the time of illness onset or the initiation and duration a Of the 14 patients studied, the most common reported symptoms were fever, myalgias, fatigue, chills, and headache. Eight (57.1%) could recall a tick bite in the past 30 days. The cases were confirmed by PCR, serology, and/or examination of peripheral smear.
of antibiotic therapy has not been established. Limitations to this study include a small population size and retrospective nature. It is therefore recommended that prospective studies involving larger population sizes be performed to strengthen the findings identified here. Of note, it is also imperative that trained, experienced microscopists be available to interpret the peripheral smears, since identifying morulae can be challenging to the untrained eye. In conclusion, we believe that analysis of the peripheral smear by trained microscopists provides a fast, effective way to confirm a diagnosis of anaplasmosis, thus promoting prompt, directed treatment.
